{"id":526105,"date":"2021-01-12T18:30:01","date_gmt":"2021-01-12T18:30:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=526105"},"modified":"2021-01-12T18:30:01","modified_gmt":"2021-01-12T18:30:01","slug":"spatial-genomics-and-transcriptomics-market-worth-404-million-by-2025-key-players-are-10x-genomics-us-nanostring-technologies-inc-us-illumina-inc-us","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/spatial-genomics-and-transcriptomics-market-worth-404-million-by-2025-key-players-are-10x-genomics-us-nanostring-technologies-inc-us-illumina-inc-us_526105.html","title":{"rendered":"Spatial Genomics and Transcriptomics Market worth $404 million by 2025 | Key Players are 10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US)"},"content":{"rendered":"
\"Spatial<\/a><\/p>\n
\n
10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US) are the prominent players operating in the transcriptomics market. Product launches, collaborations, agreements, expansions, and acquisitions are the key growth strategies adopted by a majority of the leading players in the market to gain a competitive edge in the market.<\/div>\n<\/div>\n<\/div>\n
Spatial Genomics and Transcriptomics Market Size Estimation and Analysis of Wide Range of Growth Opportunities for Industry Players.<\/div>\n

According to the new market research report “<\/strong>Spatial Genomics and Transcriptomics Market<\/a> by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Drug Discovery),End User (Academic Institute, Research Institutes, CROs)-Global Forecast to 2025″,<\/strong> published by MarketsandMarkets™, the Global Spatial Genomics Market is projected to reach USD 404 million<\/span> by 2025 from USD 178 million<\/span> in 2020, at a CAGR of 17.8% during the forecast period.<\/p>\n

Browse in-depth TOC on <\/em>“Spatial Genomics and Transcriptomics Market”<\/p>\n

<\/strong>218 – Tables
29 – Figures
201 – Pages<\/p>\n

<\/strong>Download PDF Brochure:
<\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=170900551<\/a><\/p>\n

The market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications in biomarker identification and drug discovery & development, and increasing investment in biopharmaceutical R&D.<\/p>\n

Spatial Transcriptomics techniques accounted for the largest share of the spatial genomics market<\/p>\n

<\/strong>Based on the technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. In 2019, the spatial transcriptomics techniques segment accounted for the largest share of the global transcriptomics market. Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.<\/p>\n

Academic & Research Institutes is the fastest-growing end-user segment of the market<\/p>\n

<\/strong>Based on end-users, the spatial genomics market is segmented into academic & research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. In 2019, the academic & research institutes segment accounted for the largest share of the transcriptomics market. Market growth can largely be attributed to the increase in research intensity in this end-user segment and the availability of sufficient grants and funds for research.<\/p>\n

Request Sample Pages:
https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=170900551<\/a> <\/p>\n

<\/strong>North America<\/span> accounted for the largest share of the transcriptomics market<\/p>\n

<\/strong>North America<\/span> held the largest share in the global market, followed by Europe<\/span>, with a share of 21.6%. The large share of the North American regional segment can be attributed to the presence of well-established as well as emerging market players operating in the spatial genomics market in this region.<\/p>\n

10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US) are the prominent players operating in the transcriptomics market. Product launches, collaborations, agreements, expansions, and acquisitions are the key growth strategies adopted by a majority of the leading players in the market to gain a competitive edge in the market.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/spatial-genomics-transcriptomics-market-170900551.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US) are the prominent players operating in the transcriptomics market. Product launches, collaborations, agreements, expansions, and acquisitions are the key growth strategies adopted by a majority of … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,404],"tags":[],"class_list":["post-526105","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/526105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=526105"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/526105\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=526105"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=526105"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=526105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}